1/6/REPORTS/0079/figure/F1 _detail_objectname_MR04_ TollLikeReceptorFamily.aspx.

Slides:



Advertisements
Similar presentations
MAP kinase Pathways in Yeast How are signals specified between pathways that share Common components? MAP = mitogen activated protein kinase.
Advertisements

Control of Gene Expression
SIGNALING FROM THE CELL SURFACE TO THE NUCLEUS
Lecture #8Date _________ n Chapter 19~ The Organization and Control of Eukaryotic Genomes.
The ubiquitin-proteasome system and its role in the cell cycle
Functions Receptors Signaling Chapter 11
Posttranslational modification, folding, assembly, and death 1.Covalent modifications 1)Proteolytic processing: posttranslational processing is called.
Biological Information Flow
Regulation of Gene Expression Eukaryotes
Control of Gene Expression
From the Cradle to the grave: molecular chaperones that may choose between folding and degradation By: Erica Zakhem.
Linear ubiquitination: A novel NF-κB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex 陈洁
_detail_objectname_MR04_ TollLikeReceptorFamily.aspx 1/6/REPORTS/0079/figure/F1.
Last Class 1. Transcription 2. RNA Modification and Splicing
Biology 102 Gene Regulation and Expression Part 2.
Chapter 12 B-Cell Activation and Differentiation Dr. Capers
Major Events in the Local Inflammatory Response.
B Cell Activation and Antibody Production Chapter 12.
1 Cluster of differentiation molecules.. 2 CELLSCD Number Macrophages, monocyte CD4, CD11b, CD64, CD115, CD86 (B7-2), CD80 (B7 – 1) Dendritic cell CD1a,
Protein Degradation BL Proteins have variable life-spans EnzymeHalf-lifeHours Ornithine decarboxylase0.2 RNA polymerase I1.3 Tyrosine aminotransferase2.0.
Cytokines: Introduction
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Dr. Ahmad Hameed MBBS,DCP, M.Phil
Chemokines: Introduction
Figure 2 Dicer and RISC (RNA-induced silencing complex).
Immune Receptors and Signal Transduction
Thymocyte development summary
Avoiding Immune Detection
SIGNALLING MOLECULES Hormones
Proteolysis Targeting Chimera Profacgen. In mammalian cells, protein degradation is mainly carried out by the ubiquitin- proteasome system to dispose.
LECT 21: REGULATED PROTEIN TURNOVER
Volume 13, Issue 13, Pages R514-R516 (July 2003)
Supplementary Table. Gene expression profiling reveals a decrease in NFkB-driven gene signature pattern upon treatment with MLN4924. Gene ID Name Treated/
Antibody production and B cell differentiation
T cell mediated immunity Part II
The Cbl Family and Other Ubiquitin Ligases
Control of Eukaryotic Genes
Immune System Review.
Control of Eukaryotic Genes
Biology of common β receptor–signaling cytokines
Volume 49, Issue 5, Pages (November 2008)
Eukaryote Regulation and Gene Expression
Tumor necrosis factor: Biology and therapeutic inhibitors
Roles for Chemokines in Liver Disease
DNA Replication Protein Synthesis
Schematic diagram of ubiquitin and SUMO modification pathways
Volume 53, Issue 3, Pages (September 2010)
Inflammatory and immune cells involved in chronic obstructive pulmonary disease (COPD). Inflammatory and immune cells involved in chronic obstructive pulmonary.
Pro-endometriotic niche in endometriosis
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Phagocytosis Immunity Volume 22, Issue 5, Pages (May 2005)
Protein Turnover: A CHIP Programmed for Proteolysis
The Met1-Linked Ubiquitin Machinery: Emerging Themes of (De)regulation
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Volume 19, Issue 5, Pages (September 2005)
Bacterial Interference of Ubiquitination and Deubiquitination
We Can Still Be Friends: IFN-γ Breaks Up Macrophage Enhancers
Figure 1 Extrinsic and intrinsic pathways of apoptosis
Eukaryotic Gene Regulation
Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling  Jens Demand, Simon Alberti, Cam Patterson,
NEDD8 Pathways in Cancer, Sine Quibus Non
Some major pathways controlling protein breakdown in skeletal muscle.
The development of proteasome inhibitors as anticancer drugs
Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members  Sophie Janssens, Rudi Beyaert  Molecular.
Orchestration of the immune response by dendritic cells
Figure 5 TLR-dependent signaling pathways inhibited by glatiramer acetate Myeloid differentiation primary response gene 88 (MyD88) and Toll-IL-1 receptor.
Tumor necrosis factor: Biology and therapeutic inhibitors
A new key in breast cancer metastasis
The Cbl Family and Other Ubiquitin Ligases
Presentation transcript:

http://genomebiology.com/2000/ 1/6/REPORTS/0079/figure/F1 http://www.rndsystems.com/mini_review _detail_objectname_MR04_ TollLikeReceptorFamily.aspx

NFkB http://www.stat.rice.edu/~siefert/Research/NfKB.html

The ubiquitin proteasome system The ubiquitin proteasome system. (a) Ubiquitin is activated by a ubiquitin-activating enzyme (E1) and transferred onto substrate proteins by ubiquitin-conjugating enzymes (E2) and ubiquitin ligases (E3), resulting in (b) either attachment of a single ubiquitin molecule (mono-ubiquitination), attachment of multiple ubiquitin units to several substrate lysine residues on the same protein (multi-ubiquitination) or synthesis of ubiquitin chains (poly-ubiquitination). (c) Many poly-ubiquitinated proteins are subsequently degraded by the 26S proteasome, which consists of the catalytic 20S complex and the regulatory 19S particles. Degradation substrates are either delivered to the proteasome by soluble ubiquitin receptors or recognized by the intrinsic ubiquitin-binding activity of the 19S particle. At the 19S proteasome the ubiquitin chain is disassembled, and the substrate is unfolded before it can enter the cavity of the 20S subunit where proteolysis takes place. Finally, proteolytic fragments exit the proteasome in a poorly understood way. (d) Ubiquitination can also directly regulate protein function in a proteolysis-independent manner, via mono-, multi- or poly-ubiquitinated proteins. Kaiser and Huang Genome Biology 2005 6:233   doi:10.1186/gb-2005-6-10-233

Activated Macrophages Differentiation of activated macrophages requires a priming signal in the form of IFN-γ7 via the IFN-γ R.8 When the primed macrophage subsequently encounters an appropriate stimulus, such as bacterial LPS, it becomes activated.

CXCL2 Chemokine (C-X-C motif) ligand 2 (CXCL2) is a small cytokine belonging to the CXC chemokine family that is also called macrophage inflammatory protein 2-alpha (MIP2-alpha). CCL2 Chemokine (C-C motif) ligand 2 (CCL2) is a small cytokine belonging to the CC chemokine family that is also known as monocyte chemotactic protein-1 (MCP-1). It is found at the site of tooth eruption and bone degradation. In the bone, CCL2 is expressed by mature osteoclasts and osteoblasts and is under the control of nuclear factor κB (NFκB).

Chromatin Immunoprecipitation (ChIP) assays are used to evaluate the association of proteins with specific DNA regions. http://www.collaslab.com/article.php?id=18